Evaluation of Retinal Imaging in Patients with Alzheimer’s Disease


About this study

The purpose of this study is to explore the various retinal modalities to determine if they may provide a non-invasive method of identifying populations at risk for developing Alzheimer’s Disease (AD) and predict disease progression.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients within the Mayo Clinic Study of Aging 
  • Patients 21-50 years old, 51-70 years old, and 71 and older   
  • Patients with dementia from the Mayo Clinic ADRC

Exclusion Criteria:

  • Patients with glaucoma or other optic neuropathies will be excluded

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

John Chen, M.D., Ph.D.

Closed-enrolling by invitation

What is this? (?)
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Jessica Morgan C.O.A.

(507) 293-9689


More information


Publications are currently not available

Mayo Clinic Footer